We are committed to unlocking fundamentally different therapeutic approaches and creating new solutions through bold science and our unique drug discovery platform.
Named for the visual resemblance of a scholar rock to protein structures, Scholar Rock is advancing innovative treatments where protein growth factors are fundamental. Over the past decade, we have created a pipeline with the potential to advance the standard of care for neuromuscular disease and other conditions where growth factor-targeted drugs can play a transformational role.Learn About Our Science
Scholar Rock works across therapeutic areas and shines new light on the overlooked to better target disease.
We are on a mission to discover, develop, and deliver life-changing therapies. We promote a spirit of curiosity and collaboration with the goal of achieving the best results for patients.
February 16, 2024
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 15, 2024
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 6, 2024
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management